AML-272: The Immune Checkpoint BTLA Expression: A Potential Prognostic Biomarker for Acute Myeloid Leukemia Patients

Radwan, Sara; Elleboudy, Nooran; Nabih, Nermeen; Kamal, Amany; Elkholy, Amal;

Other data

Title AML-272: The Immune Checkpoint BTLA Expression: A Potential Prognostic Biomarker for Acute Myeloid Leukemia Patients
Authors Radwan, Sara; Elleboudy, Nooran; Nabih, Nermeen; Kamal, Amany; Elkholy, Amal 
Issue Date 2020
Publisher Elsevier
Journal Clinical Lymphoma Myeloma and Leukemia
Volume 20
Start page S198

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.